Pharmaceutical Executive
Survey on the rising use of Inter Partes Reviews to challenge patents reveals key considerations for originator companies.
Eva Freel
Advertisement
Articles by Eva Freel
Advertisement
Latest Updated Articles
New Challenge to IP InnovationOctober 1st 2016
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
2
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
3
Lipid Lowering with PCSK9 Inhibition: Long-Term Efficacy, Long-Standing Barriers
4
Roche and C4 Therapeutics Expands Partnership with $1 Billion Collaboration Agreement
5